These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 24695798)

  • 1. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease.
    Xu XR; Liu CQ; Feng BS; Liu ZJ
    World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of inflammatory bowel disease.
    Wallace KL; Zheng LB; Kanazawa Y; Shih DQ
    World J Gastroenterol; 2014 Jan; 20(1):6-21. PubMed ID: 24415853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
    Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
    World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal Immunity Related to FOXP3
    Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
    J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-23 in inflammatory bowel diseases and colon cancer.
    Neurath MF
    Cytokine Growth Factor Rev; 2019 Feb; 45():1-8. PubMed ID: 30563755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.
    Raza A; Yousaf W; Giannella R; Shata MT
    Expert Rev Clin Immunol; 2012 Feb; 8(2):161-8. PubMed ID: 22288454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
    Rovedatti L; Kudo T; Biancheri P; Sarra M; Knowles CH; Rampton DS; Corazza GR; Monteleone G; Di Sabatino A; Macdonald TT
    Gut; 2009 Dec; 58(12):1629-36. PubMed ID: 19740775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Old and New Lymphocyte Players in Inflammatory Bowel Disease.
    Giuffrida P; Corazza GR; Di Sabatino A
    Dig Dis Sci; 2018 Feb; 63(2):277-288. PubMed ID: 29275447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
    Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
    Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
    Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.